Search by Drug Name or NDC

    NDC 23155-0149-05 Acarbose 100 mg/1 Details

    Acarbose 100 mg/1

    Acarbose is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is ACARBOSE.

    Product Information

    NDC 23155-0149
    Product ID 23155-149_84ff1519-f0a6-4d8f-afd3-bce6f78813aa
    Associated GPIs 27500010000340
    GCN Sequence Number 020241
    GCN Sequence Number Description acarbose TABLET 100 MG ORAL
    HIC3 C4M
    HIC3 Description ANTIHYPERGLYCEMIC, ALPHA-GLUCOSIDASE INHIBITORS
    GCN 02318
    HICL Sequence Number 008283
    HICL Sequence Number Description ACARBOSE
    Brand/Generic Generic
    Proprietary Name Acarbose
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acarbose
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name ACARBOSE
    Labeler Name Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Pharmaceutical Class alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202271
    Listing Certified Through 2024-12-31

    Package

    NDC 23155-0149-05 (23155014905)

    NDC Package Code 23155-149-05
    Billing NDC 23155014905
    Package 500 TABLET in 1 BOTTLE (23155-149-05)
    Marketing Start Date 2021-04-16
    NDC Exclude Flag N
    Pricing Information N/A